title: [The control of respiration in pulmonary fibrosis. The effect of O2 and CO2].
abstract: We have studied the mode of ventilation and chemosentivity in 10 patients suffering from pulmonary fibrosis. The total lung capacity was on average 63.5 +/- 8% of the predicted. Their static compliance was 0.078 +/- 0.05 l.cm of water. The patients were studied in the prone position breathing ambient air then on hyperoxia. The response to CO2 was assessed according to the rebreathing method of Read. The results of these patients were compared with those of 11 normal subjects. The ventilation at rest was normal, with a shortened respiratory time and a Ti/Ttot ratio which was lowered. The occlusion pressure (P0.1) was very much higher than that in normal subjects. This rise was correlated with an increase in pulmonary elastance and a reduction in vital capacity. The correction of hypoxia was without effect on the respiratory parameters. In relation to normal subjects the ventilatory response to carbon dioxide in fibrotics was decreased whilst the response of the P0.1 was increased expressing central hyperactivity. In conclusion, fibrotic patients have normal ventilation in spite of an increase in inspiratory work. This normal ventilation results from hyperactivity of the respiratory centre, as in the hyperventilation induced by carbon dioxide when at rest.
authors.affiliation: Service de Pneumologie et de Réanimation, Groupe Hospitalier Pitié-Salpêtrière, Paris.
authors.forename: S
authors.initials: S
authors.lastname: Launois
authors.forename: F
authors.initials: F
authors.lastname: Clergue
authors.forename: G
authors.initials: G
authors.lastname: Medrano
authors.forename: T
authors.initials: T
authors.lastname: Similowski
authors.forename: M
authors.initials: M
authors.lastname: Aubier
authors.forename: D
authors.initials: D
authors.lastname: Murciano
authors.forename: R
authors.initials: R
authors.lastname: Pariente
authors.forename: J P
authors.initials: JP
authors.lastname: Derenne
mesh_terms: D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D008170:Lung Compliance / Q000187:drug effects / Q000502:physiology; D008297:Male; D008449:Maximal Expiratory Flow-Volume Curves / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D010100:Oxygen / Q000097:blood / Q000494:pharmacology*; D010102:Oxygen Inhalation Therapy; D011658:Pulmonary Fibrosis / Q000503:physiopathology*; D012119:Respiration / Q000187:drug effects / Q000502:physiology*; D014109:Total Lung Capacity / Q000187:drug effects / Q000502:physiology; D014797:Vital Capacity / Q000187:drug effects / Q000502:physiology
chemical_list: D002245:Carbon Dioxide; D010100:Oxygen
vernacular_title: Contrôle de la respiration dans les fibroses pulmonaires. Effets de l'O2 et du CO2.